Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria D'Acquarica

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Future Medicinal Chemistry|October 9, 2025
Consecutive double chiral-switches strategy. ADHD methylphenidate drugs: from two racemates via racemate to enantiomerIsrael Agranat, Ilaria D'Acquarica
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 28, 2025
Racemic drugs are not necessarily less efficacious and less safe than their single-enantiomer componentsIsrael Agranat, Ilaria D'Acquarica
ACS Medicinal Chemistry Letters|February 19, 2025
Erratum: Addition to "The Death of the Strategy of Classical Chiral Switches Is an Exaggeration"Israel Agranat, Ilaria D'Acquarica
ACS Medicinal Chemistry Letters|September 18, 2024
Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug-Past and FutureIsrael Agranat, Ilaria D'Acquarica
ACS Pharmacology & Translational Science|September 19, 2024
Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy"Ilaria D'Acquarica, Israel Agranat
ACS Pharmacology & Translational Science|February 17, 2023
The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination StrategyIlaria D'Acquarica, Israel Agranat
ACS Medicinal Chemistry Letters|November 20, 2024
The Death of the Strategy of Classical Chiral Switches Is an ExaggerationIsrael Agranat, Ilaria D'Acquarica
Journal of Pharmaceutical and Biomedical Analysis|September 25, 2017
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compoundsAndrea Calcaterra, Ilaria D'Acquarica
Electrophoresis|September 16, 2003
Evaluation of teicoplanin chiral stationary phases of 3.5 and 5 microm inside diameter silica microparticles by polar-organic mode capillary electrochromatographyPaolo Catarcini, Salvatore Fanali, Carla Presutti, et al.
Journal of Separation Science|August 10, 2006
Dynamic HPLC on chiral stationary phases: a powerful tool for the investigation of stereomutation processesIlaria D'Acquarica, Francesco Gasparrini, Marco Pierini, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Future Medicinal Chemistry|October 9, 2025
Consecutive double chiral-switches strategy. ADHD methylphenidate drugs: from two racemates via racemate to enantiomerIsrael Agranat, Ilaria D'Acquarica
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 28, 2025
Racemic drugs are not necessarily less efficacious and less safe than their single-enantiomer componentsIsrael Agranat, Ilaria D'Acquarica
ACS Medicinal Chemistry Letters|February 19, 2025
Erratum: Addition to "The Death of the Strategy of Classical Chiral Switches Is an Exaggeration"Israel Agranat, Ilaria D'Acquarica
ACS Medicinal Chemistry Letters|September 18, 2024
Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug-Past and FutureIsrael Agranat, Ilaria D'Acquarica
ACS Pharmacology & Translational Science|September 19, 2024
Correction to "The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy"Ilaria D'Acquarica, Israel Agranat
ACS Pharmacology & Translational Science|February 17, 2023
The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination StrategyIlaria D'Acquarica, Israel Agranat
ACS Medicinal Chemistry Letters|November 20, 2024
The Death of the Strategy of Classical Chiral Switches Is an ExaggerationIsrael Agranat, Ilaria D'Acquarica
Journal of Pharmaceutical and Biomedical Analysis|September 25, 2017
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compoundsAndrea Calcaterra, Ilaria D'Acquarica
Electrophoresis|September 16, 2003
Evaluation of teicoplanin chiral stationary phases of 3.5 and 5 microm inside diameter silica microparticles by polar-organic mode capillary electrochromatographyPaolo Catarcini, Salvatore Fanali, Carla Presutti, et al.
Journal of Separation Science|August 10, 2006
Dynamic HPLC on chiral stationary phases: a powerful tool for the investigation of stereomutation processesIlaria D'Acquarica, Francesco Gasparrini, Marco Pierini, et al.
Pageof 6